Case study: Caring for expectant mothers with substance use disorder
With the country in the grips of an opioid epidemic, Norton Healthcare in 2015 launched the Maternal Opiate and Substance Treatment program, which makes it easy and non-stigmatizing for pregnant women with substance use disorder to access addiction treatment during obstetrical care, dramatically reducing admissions for neonatal abstinence syndrome. Read more.
Related News Articles
Perspective
More than 48 million Americans — 16.8% of the 12-and-older population — have a substance use disorder (SUD), according to the 2025 National Survey on Drug Use…
Headline
HHS awards $1.5 billion in opioid response grants to states, tribal communities The Department of Health and Human Services announced yesterday that it…
Headline
The Senate Sept. 18 passed the AHA-supported SUPPORT Act (H.R. 2483) by a voice vote, advancing the bill to President Trump to sign into law. The bill…
Headline
The National Institutes of Health Sept. 16 announced it has launched a consortium to help reduce preventable stillbirths across the U.S. The NIH said…
Headline
A blog by Julia Resnick, AHA senior director of health outcomes and care transformation, describes a new project with the Commonwealth Fund that will explore…
Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…